This is a huge step forward -- it could be the breakthrough we've been looking forResearchers report stem cell alternative Sep 27, 2008
Cloning isn't here now, but with this new technique we have the technology that might be able to actually produce a child. If this was applied to humans it would be enormously troublesomeCloning technology could be used on humans Apr 15, 2008
There's not going to be one shoe that fits allCell might sub for embryonic stem cells Jan 07, 2007
It's an exciting first step toward treating spinal cord injuries with human embryonic stem cellsStem cell therapy cures paralysis in rats May 11, 2005
Before we can get into the clinic, it's very important that we have lines that are safe for applications -- and this is where we are starting to run into problemsHealth Biz: Physicians join the P4P game Mar 10, 2005
Robert Lanza (born 11 February 1956) is an American Doctor of Medicine, scientist, Chief Scientific Officer of Advanced Cell Technology (ACT) and Adjunct Professor at the Institute for Regenerative Medicine, Wake Forest University School of Medicine.
Lanza was born in Boston, Massachusetts, and grew up south of there, in Stoughton, Massachusetts. Lanza "altered the genetics of chickens in his basement", and came to the attention of Harvard Medical School researchers when he appeared at the university with his results. Jonas Salk, B. F. Skinner, and Christiaan Barnard mentored Lanza over the next ten years. Lanza attended University of Pennsylvania, receiving BA and MD degrees. There, he was a Benjamin Franklin Scholar and a University Scholar. Lanza was a Fulbright Scholar. Lanza currently resides in Clinton, Massachusetts.
Lanza was part of the team that cloned the world's first early stage human embryos for the purpose of generating embryonic stem cells. Lanza demonstrated that techniques used in preimplantation genetic diagnosis could be used to generate embryonic stem cells without embryonic destruction.